101 related articles for article (PubMed ID: 6171884)
1. Substance P analog, DiMe-C7: evidence for stability in rat brain and prolonged central actions.
Eison AS; Iversen SD; Sandberg BE; Watson SP; Hanley MR; Iversen LL
Science; 1982 Jan; 215(4529):188-90. PubMed ID: 6171884
[TBL] [Abstract][Full Text] [Related]
2. The behavioural effects of a novel substance P analogue following infusion into the ventral tegmental area or substantia nigra of rat brain.
Eison AS; Eison MS; Iversen SD
Brain Res; 1982 Apr; 238(1):137-52. PubMed ID: 6177380
[TBL] [Abstract][Full Text] [Related]
3. Infusion of the substance P analogue, DiMe-C7, into the ventral tegmental area induces reinstatement of cocaine-seeking behaviour in rats.
Placenza FM; Fletcher PJ; Rotzinger S; Vaccarino FJ
Psychopharmacology (Berl); 2004 Dec; 177(1-2):111-20. PubMed ID: 15167979
[TBL] [Abstract][Full Text] [Related]
4. Evidence for dose-dependent positively and negatively reinforcing effects of the substance P C-terminal analog DIME-C7.
Hasenöhrl RU; Gerhardt P; Huston JP
Neuropeptides; 1990 Dec; 17(4):205-11. PubMed ID: 1709480
[TBL] [Abstract][Full Text] [Related]
5. Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area.
Elliott PJ; Alpert JE; Bannon MJ; Iversen SD
Brain Res; 1986 Jan; 363(1):145-7. PubMed ID: 2418910
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical consequences following injection of the substance P analogue, DiMe-C7, into the rat ventral tegmental area.
Barnes JM; Barnes NM; Costall B; Cox AJ; Domeney AM; Kelly ME; Naylor RJ
Pharmacol Biochem Behav; 1990 Dec; 37(4):839-41. PubMed ID: 1709506
[TBL] [Abstract][Full Text] [Related]
7. Behavioural effects of tachykinins and related peptides.
Elliott PJ; Iversen SD
Brain Res; 1986 Aug; 381(1):68-76. PubMed ID: 2428433
[TBL] [Abstract][Full Text] [Related]
8. Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat.
Hagan RM; Jones BJ; Jordan CC; Tyers MB
Br J Pharmacol; 1990 Feb; 99(2):227-32. PubMed ID: 1691672
[TBL] [Abstract][Full Text] [Related]
9. Positively reinforcing effects of the neurokinin substance P in the basal forebrain: mediation by its C-terminal sequence.
Hasenöhrl RU; Gerhardt P; Huston JP
Exp Neurol; 1992 Feb; 115(2):282-91. PubMed ID: 1370940
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonist.
Keeler JR; Charlton CG; Helke CJ
J Pharmacol Exp Ther; 1985 Jun; 233(3):755-60. PubMed ID: 2409270
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin gene-related peptide enhances substance P-induced behaviors via metabolic inhibition: in vivo evidence for a new mechanism of neuromodulation.
Mao J; Coghill RC; Kellstein DE; Frenk H; Mayer DJ
Brain Res; 1992 Mar; 574(1-2):157-63. PubMed ID: 1379108
[TBL] [Abstract][Full Text] [Related]
12. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine.
Altier N; Stewart J
J Pharmacol Exp Ther; 1998 Apr; 285(1):208-15. PubMed ID: 9536012
[TBL] [Abstract][Full Text] [Related]
13. Intra-median raphe infusions of muscimol and the substance P analogue DiMe-C7 produce hyperactivity: role of serotonin neurons.
Paris JM; Lorens SA
Behav Brain Res; 1987; 26(2-3):139-51. PubMed ID: 2447909
[TBL] [Abstract][Full Text] [Related]
14. Substance P in the dorsal vagal complex inhibits medullary TRH-induced gastric acid secretion in rats.
Yang H; Taché Y
Am J Physiol; 1997 May; 272(5 Pt 1):G987-93. PubMed ID: 9176205
[TBL] [Abstract][Full Text] [Related]
15. Intra-VTA infusions of the substance P analogue, DiMe-C7, and intra-accumbens infusions of amphetamine induce analgesia in the formalin test for tonic pain.
Altier N; Stewart J
Brain Res; 1993 Nov; 628(1-2):279-85. PubMed ID: 7508809
[TBL] [Abstract][Full Text] [Related]
16. Effects of receptor-selective neurokinin agonists and a neurokinin antagonist on the electrical activity of spinal cord neurones in culture.
Wienrich M; Reuss K; Harting J
Br J Pharmacol; 1989 Nov; 98(3):914-20. PubMed ID: 2480170
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cardiac baroreflex sensitivity after central dopaminergic stimulation.
van den Buuse M; Wilks DP; Cornish JL
Clin Exp Pharmacol Physiol; 1998; 25(7-8):624-6. PubMed ID: 9673440
[TBL] [Abstract][Full Text] [Related]
18. Regional peripheral and CNS hemodynamic effects of intrathecal administration of a substance P receptor agonist.
Helke CJ; Phillips ET; O'Neill JT
J Auton Nerv Syst; 1987 Nov; 21(1):1-7. PubMed ID: 2450116
[TBL] [Abstract][Full Text] [Related]
19. Reinforcing properties of the substance P C-fragment analog DiMe-C7 in Carassius auratus.
Mattioli R; Coelho J; Martins A
Braz J Med Biol Res; 1996 Apr; 29(4):495-9. PubMed ID: 8736114
[TBL] [Abstract][Full Text] [Related]
20. A functional interaction between the mesolimbic dopamine system and vasopressin release in the regulation of blood pressure in conscious rats.
Cornish JL; Wilks DP; Van den Buuse M
Neuroscience; 1997 Nov; 81(1):69-78. PubMed ID: 9300402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
